Ocular cuts jobs post FDA rejection
Ocular Therapeutix has announced it is laying off 19% of its workforce in order to cut operating expenses.
Ocular Therapeutix has announced it is laying off 19% of its workforce in order to cut operating expenses.
BASF has set up a pharmaceutical technical laboratory in Navi Mumbai, India citing Asia’s fast growing generic drug manufacturing sector as its target customer base.
Revenue generated by Pfizer’s API and contracting business fell in the second quarter.
SGS North America completed a four day-audit of Envigo’s laboratory animal diet facility.
Melinta Therapeutics has hired ScinoPharm to make the active pharmaceutical ingredient (API) for Baxdela, an antibiotic for skin infections that was recently approved by the US FDA.
Başkent University’s hospital cluster has joined Clinerion’s Patient Recruitment System (PRS) Platform, expanding sponsor access to potential clinical trial participants.